发明名称 |
Stabilized tolterodine tartrate formulations |
摘要 |
A method of making a pharmaceutical composition containing tolterodine L-tartrate stabilized against degradation with an acid. Acid-stabilized tolterodine L-tartrate may be used as an active ingredient in various types of immediate release and controlled release dosage forms, including tablets, capsules, and beads. |
申请公布号 |
US8778397(B2) |
申请公布日期 |
2014.07.15 |
申请号 |
US201313915367 |
申请日期 |
2013.06.11 |
申请人 |
Mylan, Inc. |
发明人 |
Rossi David T.;Li Boyong;McCall James Paul |
分类号 |
A61K31/135;A61K9/20;A61K9/24;A61P43/00 |
主分类号 |
A61K31/135 |
代理机构 |
Kramer Amado, P.C. |
代理人 |
Kramer Amado, P.C. |
主权项 |
1. A method of making a drug-containing bead, said method comprising the steps of:
combining tolterodine-L-tartrate with a stabilizing amount of a pharmaceutically acceptable non-polymeric pH-modifying acid having a pKa of less than 5.0 to obtain an acid-stabilized tolterodine-L-tartrate composition which does not contain oxybutynin; depositing a seal layer on an inert core, said seal layer being formed from a non-polymeric hydrophobic material; and depositing a layer containing said acid-stabilized tolterodine-L-tartrate on said seal layer. |
地址 |
Morgantown WV US |